海特生物(300683) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥166,366,483.37, an increase of 9.47% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2024 was -¥16,977,990.17, a decrease of 10.88% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥23,152,603.59, down 22.64% from the previous year[3]. - The company’s basic earnings per share for Q3 2024 was -¥0.13, a decrease of 8.33% year-on-year[3]. - The company reported a net profit of ¥7,530,944.09 for Q3 2024, compared to ¥2,986,990.70 in Q3 2023, indicating a significant increase in profitability[17]. - The net profit for the third quarter of 2024 was -42,198,124.87 CNY, compared to -29,616,167.81 CNY in the same period last year, representing an increase in net loss of approximately 42.3%[18]. - Operating income for the third quarter was -49,306,511.94 CNY, a decline from -43,073,876.78 CNY year-over-year[18]. - The company’s total profit for the quarter was -51,538,690.13 CNY, compared to -49,172,883.98 CNY in the same period last year, indicating a decline in profitability[18]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥27,741,059.46, an increase of 163.36% compared to the same period last year[3]. - The company received cash related to operating activities amounting to ¥96,890,130.39, an increase of 237.01% compared to the previous period, primarily due to increased government subsidies and deposits[9]. - Cash flow from operating activities generated a net inflow of 27,741,059.46 CNY, a significant recovery from a net outflow of -43,779,885.16 CNY in the previous year[20]. - Total cash inflow from operating activities was 522,280,342.04 CNY, compared to 488,848,937.13 CNY in the prior year, indicating a year-over-year increase of approximately 6.7%[20]. - Cash flow from investing activities resulted in a net outflow of -27,744,906.50 CNY, an improvement from -484,885,228.11 CNY in the same period last year[20]. Assets and Liabilities - Total assets as of the end of Q3 2024 were ¥2,943,663,973.18, a decrease of 0.93% from the beginning of the year[4]. - Current assets totaled ¥1,320,771,206.51, down from ¥1,488,199,258.13 at the start of the year, indicating a decline of approximately 11.3%[16]. - Non-current assets increased to ¥1,622,892,766.67 from ¥1,483,051,898.49, representing a growth of about 9.4%[16]. - The company's total liabilities were ¥490,133,043.21, compared to ¥475,730,321.80 at the beginning of the year, marking an increase of 3.1%[16]. - The cash and cash equivalents at the end of Q3 2024 were ¥495,054,826.68, down from ¥510,216,050.96 at the beginning of the year[16]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 11,418, with the largest shareholder, Wuhan Sanjiangyuan Investment Development Co., Ltd., holding 19.26% of shares[10]. - The company’s major shareholders include Wuhan Sanjiangyuan Investment Development Co., Ltd. and Wuhan Beirui Enterprise Management Co., Ltd., holding 19.26% and 11.30% of shares, respectively[10]. Operating Costs and Expenses - Total operating costs for Q3 2024 were ¥533,194,046.61, up from ¥506,037,628.53 in the same period last year, reflecting a year-over-year increase of 5.5%[17]. - The company incurred a total operating expense of 494,539,282.58 CNY, down from 532,628,822.29 CNY in the previous year, reflecting a decrease of approximately 7.1%[20]. - Research and development expenses amounted to ¥89,029,216.08 in Q3 2024, slightly down from ¥90,738,631.99 in Q3 2023[17]. Other Income and Financial Assets - The company reported a significant increase in other income, which rose by 168.98% to ¥22,132,566.45 due to increased government subsidies[8]. - The company experienced a 33.90% decrease in trading financial assets, primarily due to the maturity of financial products during the reporting period[7]. - Investment income cash received was ¥13,950,096.01, reflecting a 43.35% increase, mainly due to higher returns from financial products maturing during the reporting period[9]. - The company reported a significant decrease in cash received from the disposal of fixed assets, intangible assets, and other long-term assets, which fell by 99.27% to ¥15,000.00[9]. - The company did not receive any cash from investments during the reporting period, a 100% decrease compared to the previous year, due to a lack of stock issuance[9].